FAIRVASC receives @EU_H2020 Research & Innovation Programme funding under EJP RD COFUND-EJP N° 825575. Tweets reflect only the views of the project owner.
FAIRVASC is a Horizon 2020 funded research project of EUVAS and RITA ERN, bringing together leading scientists, clinicians and patient organisations to build registry interoperability to inform clinical care.
📣Eosinophilic lung diseases can be tricky: multiple etiologies, overlapping clinical and radiologic features, and a high risk of misdiagnosis.
Don’t miss this brillant new review✨
https://t.co/L0jDgBvFvg
Presented today in Breakout Session 1 at the 22nd international vasculitis workshop in Melbourne.
“DCVAS and the 2022 ACR/EULAR classifications of ANCA-associated vasculitis – how are they performing?”
Excellent discussion on real-world performance of classification criteria.
✨ A big thank you to everyone for such a wonderful and inspiring day at the 𝟭𝟬𝘁𝗵 𝗘𝘂𝗿𝗼𝗽𝗲𝗮𝗻 𝗘𝗚𝗣𝗔 𝗦𝘁𝘂𝗱𝘆 𝗚𝗿𝗼𝘂𝗽 𝗠𝗲𝗲𝘁𝗶𝗻𝗴 hosted in the magnificent setting of the Maison de l’Amérique Latine, Paris🇫🇷
A unique opportunity for exchange and collaboration🤝
Say g'day to Kiwa the Koala - our (unofficial but totally adorable) mascot! Subscribe to our e-newsletter to follow all the latest updates on #VasculitisMelbourne2026 and to follow Kiwa's adventures around Australia (and beyond)!
Visit https://t.co/h9nW5qoMpY to subscribe🐨
🔦Don't miss the scientific session: "Spotlight on Small Vessel Vasculitis" at #EULAR2025
🧠 Watch experts tackle real cases live.
💬 Compare your treatment approach with the pros.
📍 Thursday, 12 June 2025 | 13:30 CEST | Room B2.
Explore more👉https://t.co/TtUWIh3Q96
#EULAR
Don’t miss the latest review published in @NatRevRheumatol on advances in the treatment of ANCA-associated vasculitis (AAV) — a must-read update for anyone!
https://t.co/7qmgSxgXvf
Many thanks to the authors for their valuable contribution! 👏 #AAV#vasculitis
THIS IS #VASCULITIS AWARENESS DAY !!! HERE AT THE #PARADISEPROJECT, SCIENTISTS, CLINICIANS, RESEARCHERS, NEPHROLOGISTS, STATISTICIANS, DATA ANALYSTS, #AI SPECIALISTS, AND PATIENTS COLLABORATE TO IMPROVE #VASCULITIS PATIENTS' OUTCOMES.
#VAM2025
Interested in vasculitis? Don’t miss the 6th EUVAS Vasculitis Course! May 21–24, 2025. Trieste, Italy !
Stay up to date with the latest in vasculitis
The course is fully booked for onsite participation. But available online. – register today!
https://t.co/JHzkMqiZ1g
Don't forget vasculitis when it comes to the rare and wonderful on #RareDiseaseDay! Support their cause on https://t.co/RVegUNByOS.
And for more in-depth discussion on vasculitis, why not pay us a visit down under for the International Vasculitis Workshop 2026! #IVW2026
Come join us for #IVW2026 in Australia, and in the vibrant city of Melbourne! February offers perfect summer weather - ideal for beach trips and exploring the city’s famous laneways. Join the Mailing List (https://t.co/h9nW5qpkfw) to keep up to date!
Mark Little, our coordinator, presented a very catchy vision of @PARADISE__AI project during the #EPPerMed Conference on Personalised Medicine Research.
#RareDiseaseDay#RareDisease IgA #Vasculitis usually affects young children but also affects adults of all ages. It has the potential to affect the gastro tract & kidneys and is often more difficult to treat and manage in older children and adults. https://t.co/kmWybhgRNX
@PARADISE__AI has been selected to be part of the first EP PerMed Conference on Personalised Medicine Research on 11 and 12 February 2025 in Berlin (Germany). @kiplet69 will give a presentation about our Project.
https://t.co/o3I3b66iYG